| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 3308-3315, Copyright © 1996 by Endocrine Society
ARTICLES |
D Salvatore, T Bartha, JW Harney and PR Larsen
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Type 2 deiodinase (D2) is a low K(m) iodothyronine deiodinase that catalyzes the removal of a single iodine from the phenolic ring of T4 or rT3. We sequenced and subcloned the open reading frame from a partial complementary DNA (cDNA) clone (2.1 kilobases) prepared by Genethon (Z44085) from a human infant brain cDNA library. The open reading frame encodes a putative 273-amino acid protein of 31 kDa with greater than 70% similarity to the Rana catesbeiana D2 protein. Transient expression of the cDNA produces a low K(m) (5 nM for T4; 8 nM for rT3) propylthiouracil- and gold thioglucose-resistant 5'-deiodinase in 293-HEK cells. Human D2, like human type 1 (D1) and type 3 (D3) deiodinases, is a selenoenzyme, as evidenced by 1) the presence of two in-frame UGA codons (positions 133 and 266), 2) the synthesis of a 31- kDa 75Selabeled protein in D2 cDNA-transfected cells, and 3) the requirement for a 3'-selenocysteine incorporation sequence element for its translation. Unlike D1 and D3, we were not able to covalently label overexpressed D2 with N-bromoacetyl [125I]T3 or -T4. We found that the human D2 messenger RNA is 7-8 kilobases and is expressed in brain, placenta, and, surprisingly, cardiac and skeletal muscle. Type 2 deiodinase activity was also present in human skeletal muscle. These results indicate that there are unique features of D2 that distinguish it from the two other selenodeiodinases. The expression of D2 in muscle suggests that it could play a role in peripheral, as well as intracellular, T3 production.
This article has been cited by other articles:
![]() |
B. Anguiano, N. Aranda, G. Delgado, and C. Aceves Epididymis Expresses the Highest 5'-Deiodinase Activity in the Male Reproductive System: Kinetic Characterization, Distribution, and Hormonal Regulation Endocrinology, August 1, 2008; 149(8): 4209 - 4217. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mebis, L. Langouche, T. J. Visser, and G. Van den Berghe The Type II Iodothyronine Deiodinase Is Up-Regulated in Skeletal Muscle during Prolonged Critical Illness J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3330 - 3333. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension Hypertension, March 1, 2007; 49(3): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Silva Thermogenic Mechanisms and Their Hormonal Regulation Physiol Rev, April 1, 2006; 86(2): 435 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, S. van der Geyten, P. J. Wouters, V. M. Darras, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe Tissue Thyroid Hormone Levels in Critical Illness J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6498 - 6507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Debaveye, B. Ellger, L. Mebis, E. Van Herck, W. Coopmans, V. Darras, and G. Van den Berghe Tissue Deiodinase Activity during Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone-Releasing Peptide-2 Endocrinology, December 1, 2005; 146(12): 5604 - 5611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dentice, C. Luongo, A. Elefante, R. Ambrosio, S. Salzano, M. Zannini, R. Nitsch, R. Di Lauro, G. Rossi, G. Fenzi, et al. Pendrin Is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells Mol. Cell. Biol., November 15, 2005; 25(22): 10171 - 10182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roos, S. P. Linn-Rasker, R. T. van Domburg, J. P. Tijssen, and A. Berghout The Starting Dose of Levothyroxine in Primary Hypothyroidism Treatment: A Prospective, Randomized, Double-blind Trial Arch Intern Med, August 8, 2005; 165(15): 1714 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kahaly and W. H. Dillmann Thyroid Hormone Action in the Heart Endocr. Rev., August 1, 2005; 26(5): 704 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, P. J. Wouters, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe Serum 3,3',5'-Triiodothyronine (rT3) and 3,5,3'-Triiodothyronine/rT3 Are Prognostic Markers in Critically Ill Patients and Are Associated with Postmortem Tissue Deiodinase Activities J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4559 - 4565. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, A. W. van den Beld, H. Attalki, H. v. Toor, Y. B. de Rijke, G. G. J. M. Kuiper, S. W. J. Lamberts, J. A. M. J. L. Janssen, A. G. Uitterlinden, and T. J. Visser A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E75 - E81. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Canani, C. Capp, J. M. Dora, E. L. S. Meyer, M. S. Wagner, J. W. Harney, P. R. Larsen, J. L. Gross, A. C. Bianco, and A. L. Maia The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3472 - 3478. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin Endocrinology, April 1, 2005; 146(4): 2077 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Santini, A. Pinchera, A. Marsili, G. Ceccarini, M. G. Castagna, R. Valeriano, M. Giannetti, D. Taddei, R. Centoni, G. Scartabelli, et al. Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid Diseases J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 124 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yasuzawa-Amano, N. Toyoda, A. Maeda, A. Kosaki, Y. Mori, T. Iwasaka, and M. Nishikawa Expression and Regulation of Type 2 Iodothyronine Deiodinase in Rat Aorta Media Endocrinology, December 1, 2004; 145(12): 5638 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. J. S. Wassen, W. Klootwijk, E. Kaptein, D. J. Duncker, T. J. Visser, and G. G. J. M. Kuiper Characteristics and Thyroid State-Dependent Regulation of Iodothyronine Deiodinases in Pigs Endocrinology, September 1, 2004; 145(9): 4251 - 4263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Carvalho-Bianco, B. W. Kim, J. X. Zhang, J. W. Harney, R. S. Ribeiro, B. Gereben, A. C. Bianco, U. Mende, and P. R. Larsen Chronic Cardiac-Specific Thyrotoxicosis Increases Myocardial {beta}-Adrenergic Responsiveness Mol. Endocrinol., July 1, 2004; 18(7): 1840 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2 Mol. Endocrinol., December 1, 2003; 17(12): 2603 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Callebaut, C. Curcio-Morelli, J.-P. Mornon, B. Gereben, C. Buettner, S. Huang, B. Castro, T. L. Fonseca, J. W. Harney, P. R. Larsen, et al. The Iodothyronine Selenodeiodinases Are Thioredoxin-fold Family Proteins Containing a Glycoside Hydrolase Clan GH-A-like Structure J. Biol. Chem., September 19, 2003; 278(38): 36887 - 36896. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chan, S. Kachilele, E. Hobbs, J. N. Bulmer, K. Boelaert, C. J. McCabe, P. M. Driver, A. R. Bradwell, M. Kester, T. J. Visser, et al. Placental Iodothyronine Deiodinase Expression in Normal and Growth-Restricted Human Pregnancies J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4488 - 4495. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dentice, C. Morisco, M. Vitale, G. Rossi, G. Fenzi, and D. Salvatore The Different Cardiac Expression of the Type 2 Iodothyronine Deiodinase Gene between Human and Rat Is Related to the Differential Response of the dio2 Genes to Nkx-2.5 and GATA-4 Transcription Factors Mol. Endocrinol., August 1, 2003; 17(8): 1508 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, P. J. Wouters, E. Kaptein, H. van Toor, T. J. Visser, and G. Van den Berghe Reduced Activation and Increased Inactivation of Thyroid Hormone in Tissues of Critically Ill Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3202 - 3211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Nguyen, K. A. Mol, and J. J. DiStefano III Thyroid hormone production rates in rat liver and intestine in vivo: a novel graph theory and experimental solution Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E171 - E181. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Lisboa, K. J. Oliveira, A. Cabanelas, T. M. Ortiga-Carvalho, and C. C. Pazos-Moura Acute cold exposure, leptin, and somatostatin analog (octreotide) modulate thyroid 5'-deiodinase activity Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1172 - E1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Friedrichsen, S. Christ, H. Heuer, M. K. H. Schafer, A. Mansouri, K. Bauer, and T. J. Visser Regulation of Iodothyronine Deiodinases in the Pax8-/- Mouse Model of Congenital Hypothyroidism Endocrinology, March 1, 2003; 144(3): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Curcio-Morelli, B. Gereben, A. M. Zavacki, B. W. Kim, S. Huang, J. W. Harney, P. R. Larsen, and A. C. Bianco In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases Endocrinology, March 1, 2003; 144(3): 937 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montero-Pedrazuela, J. Bernal, and A. Guadano-Ferraz Divergent Expression of Type 2 Deiodinase and the Putative Thyroxine-Binding Protein p29, in Rat Brain, Suggests that They Are Functionally Unrelated Proteins Endocrinology, March 1, 2003; 144(3): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression Mol. Endocrinol., July 1, 2002; 16(7): 1667 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. J. Verhoelst, K. Vandenborne, T. Severi, O. Bakker, B. Zandieh Doulabi, J. L. Leonard, E. R. Kuhn, S. van der Geyten, and V. M. Darras Specific Detection of Type III Iodothyronine Deiodinase Protein in Chicken Cerebellar Purkinje Cells Endocrinology, July 1, 2002; 143(7): 2700 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor Endocrinology, April 1, 2002; 143(4): 1190 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, O. Araki, Y. Hosoi, Y. Kamiya, T. Morimura, T. Ogiwara, H. Mizuma, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Human Thyroid Gland Endocrinology, July 1, 2001; 142(7): 2961 - 2967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peeters, C. Fekete, C. Goncalves, G. Legradi, H. M. Tu, J. W. Harney, A. C. Bianco, R. M. Lechan, and P. R. Larsen Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E54 - E61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Chanoine, J. Nève, S. Wu, J. Vanderpas, and P. Bourdoux Selenium Decreases Thyroglobulin Concentrations But Does Not Affect the Increased Thyroxine-to-Triiodothyronine Ratio in Children with Congenital Hypothyroidism J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1160 - 1163. [Abstract] [Full Text] |
||||
![]() |
H. Mizuma, M. Murakami, and M. Mori Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells : Expression of Type II Iodothyronine Deiodinase Circ. Res., February 16, 2001; 88(3): 313 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pachucki, J. Hopkins, R. Peeters, H. Tu, S. D. Carvalho, H. Kaulbach, E. D. Abel, F. E. Wondisford, J. S. Ingwall, and P. R. Larsen Type 2 Iodothyronine Deiodinase Transgene Expression in the Mouse Heart Causes Cardiac-Specific Thyrotoxicosis Endocrinology, January 1, 2001; 142(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, D. Salvatore, J. W. Harney, H. M. Tu, and P. R. Larsen The Human, but Not Rat, dio2 Gene Is Stimulated by Thyroid Transcription Factor-1 (TTF-1) Mol. Endocrinol., January 1, 2001; 15(1): 112 - 124. [Abstract] [Full Text] |
||||
![]() |
C. Buettner, J. W. Harney, and P. R. Larsen The Role of Selenocysteine 133 in Catalysis by the Human Type 2 Iodothyronine Deiodinase Endocrinology, December 1, 2000; 141(12): 4606 - 4612. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gereben, C. Goncalves, J. W. Harney, P. R. Larsen, and A. C. Bianco Selective Proteolysis of Human Type 2 Deiodinase: A Novel Ubiquitin-Proteasomal Mediated Mechanism for Regulation of Hormone Activation Mol. Endocrinol., November 1, 2000; 14(11): 1697 - 1708. [Abstract] [Full Text] |
||||
![]() |
G. Canettieri, F. S. Celi, G. Baccheschi, L. Salvatori, M. Andreoli, and M. Centanni Isolation of Human Type 2 Deiodinase Gene Promoter and Characterization of a Functional Cyclic Adenosine Monophosphate Response Element Endocrinology, May 1, 2000; 141(5): 1804 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steinsapir, A. C. Bianco, C. Buettner, J. Harney, and P. R. Larsen Substrate-Induced Down-Regulation of Human Type 2 Deiodinase (hD2) Is Mediated through Proteasomal Degradation and Requires Interaction with the Enzyme's Active Center Endocrinology, March 1, 2000; 141(3): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bartha, S.-W. Kim, D. Salvatore, B. Gereben, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase Gene Endocrinology, January 1, 2000; 141(1): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hosoi, M. Murakami, H. Mizuma, T. Ogiwara, M. Imamura, and M. Mori Expression and Regulation of Type II Iodothyronine Deiodinase in Cultured Human Skeletal Muscle Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3293 - 3300. [Abstract] [Full Text] |
||||
![]() |
J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kühn, J. L. Leonard, and T. J. Visser Cloning and Characterization of Type III Iodothyronine Deiodinase from the Fish Oreochromis niloticus Endocrinology, August 1, 1999; 140(8): 3666 - 3673. [Abstract] [Full Text] |
||||
![]() |
B. Gereben, T. Bartha, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen Cloning and Expression of the Chicken Type 2 Iodothyronine 5'-Deiodinase J. Biol. Chem., May 14, 1999; 274(20): 13768 - 13776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Leonard, D. M. Leonard, M. Safran, R. Wu, M. L. Zapp, and A. P. Farwell The Mammalian Homolog of the Frog Type II Selenodeiodinase Does Not Encode a Functional Enzyme in the Rat Endocrinology, May 1, 1999; 140(5): 2206 - 2215. [Abstract] [Full Text] |
||||
![]() |
S. Incerpi, P. Luly, P. De Vito, and R. N. Farias Short-Term Effects of Thyroid Hormones on the Na/H Antiport in L-6 Myoblasts: High Molecular Specificity for 3,3',5-Triiodo-L-Thyronine Endocrinology, February 1, 1999; 140(2): 683 - 689. [Abstract] [Full Text] |
||||
![]() |
A. D. Smith, C. A. Guidry, V. C. Morris, and O. A. Levander Aurothioglucose Inhibits Murine Thioredoxin Reductase Activity In Vivo J. Nutr., January 1, 1999; 129(1): 194 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buettner, J. W. Harney, and P. R. Larsen The 3'-Untranslated Region of Human Type 2 Iodothyronine Deiodinase mRNA Contains a Functional Selenocysteine Insertion Sequence Element J. Biol. Chem., December 11, 1998; 273(50): 33374 - 33378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Kim, J. W. Harney, and P. R. Larsen Studies of the Hormonal Regulation of Type 2 5'-Iodothyronine Deiodinase Messenger Ribonucleic Acid in Pituitary Tumor Cells Using Semiquantitative Reverse Transcription-Polymerase Chain Reaction Endocrinology, December 1, 1998; 139(12): 4895 - 4905. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Nguyen, F. Chapa, and J. J. DiStefano III Direct Measurement of the Contributions of Type I and Type II 5'-Deiodinases to Whole Body Steady State 3,5,3'-Triiodothyronine Production from Thyroxine in the Rat Endocrinology, November 1, 1998; 139(11): 4626 - 4633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Richard, R. Hume, E. Kaptein, J. P. Sanders, H. van Toor, W. W. de Herder, J. C. den Hollander, E. P. Krenning, and T. J. Visser Ontogeny of Iodothyronine Deiodinases in Human Liver J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2868 - 2874. [Abstract] [Full Text] |
||||
![]() |
S. Van der Geyten, J. P. Sanders, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Expression of Chicken Hepatic Type I and Type III Iodothyronine Deiodinases during Embryonic Development Endocrinology, December 1, 1997; 138(12): 5144 - 5152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser Characterization of a Propylthiouracil-Insensitive Type I Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5153 - 5160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase Endocrinology, December 1, 1997; 138(12): 5452 - 5458. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Tu, S.-W. Kim, D. Salvatore, T. Bartha, G. Legradi, P. R. Larsen, and R. M. Lechan Regional Distribution of Type 2 Thyroxine Deiodinase Messenger Ribonucleic Acid in Rat Hypothalamus and Pituitary and Its Regulation by Thyroid Hormone Endocrinology, August 1, 1997; 138(8): 3359 - 3368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pallud, A.-M. Lennon, M. Ramauge, J.-M. Gavaret, W. Croteau, M. Pierre, F. Courtin, and D. L. St. Germain Expression of the Type II Iodothyronine Deiodinase in Cultured Rat Astrocytes Is Selenium-dependent J. Biol. Chem., July 18, 1997; 272(29): 18104 - 18110. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mol, S. van der Geyten, V. M. Darras, T. J. Visser, and E. R. Kuhn Characterization of Iodothyronine Outer Ring and Inner Ring Deiodinase Activities in the Blue Tilapia, Oreochromis Aureus Endocrinology, May 1, 1997; 138(5): 1787 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Curcio, M. M. A. Baqui, D. Salvatore, B. H. Rihn, S. Mohr, J. W. Harney, P. R. Larsen, and A. C. Bianco The Human Type 2 Iodothyronine Deiodinase Is a Selenoprotein Highly Expressed in a Mesothelioma Cell Line J. Biol. Chem., August 3, 2001; 276(32): 30183 - 30187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Leonard, S. J. Stachelek, M. Safran, A. P. Farwell, T. F. Kowalik, and J. L. Leonard Cloning, Expression, and Functional Characterization of the Substrate Binding Subunit of Rat Type II Iodothyronine 5'-Deiodinase J. Biol. Chem., August 11, 2000; 275(33): 25194 - 25201. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE |